HER2-ve Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2-ve Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients. (NCT03286842) | AstraZeneca | 2018-01-17 |
Track HER2-ve Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.